Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cullinan Therapeutics, Inc. | 506,226 | reported | 12 Jan 2021 | tx 2+435,832 |
| XOMA Royalty Corp | 116,245 | reported | 20 Apr 2026 | tx 22+917,595−200,372 |
| C4 Therapeutics, Inc. | 35,500 | reported | 18 Jun 2025 | tx 3+120,000 |
| ImageneBio, Inc. | 17,520 | reported | 07 Jun 2024 | tx 3+70,080 |
| ANAPTYSBIO, INC | 11,250 | reported | 11 May 2026 | tx 1+11,250 |
| MPM ACQUISITION CORP | 0 | reported | 15 Aug 2022 | tx 22+265,294−74,494 |
| Translate Bio, Inc. | 0 | reported | 14 Sept 2021 | tx 8+57,800−125,795 |
| FS Development Corp. II | 0 | reported | 23 Dec 2021 | tx 4+82,500−82,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 11,250 | 0.00 USD | deriv |
| 20 Apr 2026 | EXERCISE | XOMA Royalty Corp | 10,568 | 0.00 USD | |
| 20 Apr 2026 | EXERCISE | XOMA Royalty Corp | 10,568 | 0.00 USD | deriv |
| 16 Mar 2026 | GRANT_AWARD | XOMA Royalty Corp | 82,428 | 0.00 USD | |
| 16 Mar 2026 | GRANT_AWARD | XOMA Royalty Corp | 126,813 | 0.00 USD | deriv |
| 04 Dec 2025 | PURCHASE | XOMA Royalty Corp | 100,000 | 25.05 USD | first after silence |
| 19 Sept 2025 | EXERCISE | XOMA Royalty Corp | 35,567 | 0.00 USD | |
| 19 Sept 2025 | EXERCISE | XOMA Royalty Corp | 35,567 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 35,500 | 0.00 USD | deriv |
| 19 May 2025 | EXERCISE | XOMA Royalty Corp | 53,359 | 0.00 USD | |
| 20 May 2025 | SALE | XOMA Royalty Corp | 25,637 | 25.38 USD | |
| 19 May 2025 | EXERCISE | XOMA Royalty Corp | 53,359 | 0.00 USD | deriv |
| 13 Nov 2024 | SALE | XOMA Royalty Corp | 21,881 | 29.95 USD | |
| 11 Nov 2024 | EXERCISE | XOMA Royalty Corp | 53,360 | 0.00 USD | |
| 11 Nov 2024 | EXERCISE | XOMA Royalty Corp | 53,360 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 32,500 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | ImageneBio, Inc. | 17,520 | 0.00 USD | deriv |
| 08 Jan 2024 | GRANT_AWARD | XOMA Royalty Corp | 275,000 | 0.00 USD | deriv |
| 16 Nov 2023 | GRANT_AWARD | C4 Therapeutics, Inc. | 52,000 | 0.00 USD | deriv |
| 02 Oct 2023 | PURCHASE | XOMA Royalty Corp | 1,000 | 13.83 USD | |
| 26 Sept 2023 | PURCHASE | XOMA Royalty Corp | 2,499 | 14.43 USD | |
| 25 Sept 2023 | PURCHASE | XOMA Royalty Corp | 1 | 14.65 USD | |
| 09 Jun 2023 | GRANT_AWARD | ImageneBio, Inc. | 17,520 | 0.00 USD | deriv |
| 24 May 2023 | PURCHASE | XOMA Royalty Corp | 1,032 | 23.79 USD | |
| 23 May 2023 | PURCHASE | XOMA Royalty Corp | 768 | 23.49 USD | first after silence |
2 purchases reported after at least 12 months of silence — most recent on 04 Dec 2025.